Repair work on the Midtown Manhattan high-rise that dangerously buckled over the summer is reportedly slated to begin shortly ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash ...

The stock has outperformed the market this year, and it still looks heavily undervalued.

The dividend is probably the reason investors hold Pfizer (PFE), the maker of medicines such as Eliquis and Padcev. The stock ...

Pfizer Inc. (ISIN US7170811035) was trading at EUR 26.39 at Lang & Schwarz on October 20, 2026, 1.03 percent above the Xetra ...

Kraft Heinz (KHC:NYSE) yields 7.2% today, and Pfizer (PFE:NYSE) isn't far behind at 6.3%. Their second-quarter results in early August told very different stories. Pfizer raised its 2026 revenue ...

A rotation out of artificial-intelligence-driven tech names into higher-yielding, defensive healthcare stocks is gathering ...

Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth ...

GLP-1s were associated with fewer psychiatric hospitalizations and emergency department visits, suggesting potential benefits ...

Last week, drugmaker Pfizer (NYSE: PFE) declared a $0.43 fourth-quarter dividend, its 352nd consecutive quarterly dividend. The forward annual dividend, therefore, is $1.72 per share, which represents ...

Soda, toothpaste, phone service, electricity, and prescription drugs all share one trait: people keep buying them when the ...